TrialBioMed research international2022

Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial.

Bo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.